13 results on '"Ebers, George"'
Search Results
2. Inactive or moderately active human promoters are enriched for inter-individual epialleles.
- Author
-
Gemma, Carolina, Ramagopalan, Sreeram V., Down, Thomas A., Beyan, Huriya, Hawa, Mohammed I., Holland, Michelle L., Hurd, Paul J., Giovannoni, Gavin, Leslie, R. David, Ebers, George C., and Rakyan, Vardhman K.
- Published
- 2013
- Full Text
- View/download PDF
3. Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease.
- Author
-
Handel, Adam E., Sandve, Geir K., Disanto, Giulio, Berlanga-Taylor, Antonio J., Gallone, Giuseppe, Hanwell, Heather, Drabløs, Finn, Giovannoni, Gavin, Ebers, George C., and Ramagopalan, Sreeram V.
- Subjects
VITAMIN D receptors ,CD4 antigen ,AUTOIMMUNE disease treatment ,LIQUID chromatography-mass spectrometry ,FUNCTIONAL genomics - Abstract
Background: Vitamin D insufficiency has been implicated in autoimmunity. ChIP-seq experiments using immune cell lines have shown that vitamin D receptor (VDR) binding sites are enriched near regions of the genome associated with autoimmune diseases. We aimed to investigate VDR binding in primary CD4+ cells from healthy volunteers. Methods: We extracted CD4+ cells from nine healthy volunteers. Each sample underwent VDR ChIP-seq. Our results were analyzed in relation to published ChIP-seq and RNA-seq data in the Genomic HyperBrowser. We used MEMEChIP for de novo motif discovery. 25-Hydroxyvitamin D levels were measured using liquid chromatography- tandem mass spectrometry and samples were divided into vitamin D sufficient (25(OH)D ⩾75 nmol/L) and insufficient/deficient (25(OH)D <75 nmol/L) groups. Results: We found that the amount of VDR binding is correlated with the serum level of 25-hydroxyvitamin D (r = 0.92, P= 0.0005). In vivo VDR binding sites are enriched for autoimmune disease associated loci, especially when 25-hydroxyvitamin D levels (25(OH)D) were sufficient (25(OH)D ⩾75: 3.13-fold, P<0.0001; 25(OH)D <75: 2.76-fold, P<0.0001; 25(OH)D ⩾75 enrichment versus 25(OH)D <75 enrichment: P= 0.0002). VDR binding was also enriched near genes associated specifically with T-regulatory and T-helper cells in the 25(OH)D ⩾75 group. MEME ChIP did not identify any VDR-like motifs underlying our VDR ChIP-seq peaks. Conclusion: Our results show a direct correlation between in vivo 25-hydroxyvitamin D levels and the number of VDR binding sites, although our sample size is relatively small. Our study further implicates VDR binding as important in gene-environment interactions underlying the development of autoimmunity and provides a biological rationale for 25-hydroxyvitamin D sufficiency being based at 75 nmol/L. Our results also suggest that VDR binding in response to physiological levels of vitamin D occurs predominantly in a VDR motif-independent manner. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
4. Genetic, environmental and stochastic factors in monozygotic twin discordance with a focus on epigenetic differences.
- Author
-
Czyz, Witold, Morahan, Julia M., Ebers, George C., and Ramagopalan, Sreeram V.
- Subjects
EPIGENETICS ,GENOTYPE-environment interaction ,HERITABILITY ,TWINS ,HUMAN phenotype ,HUMAN genetic variation - Abstract
Genetic-epidemiological studies on monozygotic (MZ) twins have been used for decades to tease out the relative contributions of genes and the environment to a trait. Phenotypic discordance in MZ twins has traditionally been ascribed to non-shared environmental factors acting after birth, however recent data indicate that this explanation is far too simple. In this paper, we review other reasons for discordance, including differences in the in utero environment, genetic mosaicism, and stochastic factors, focusing particularly on epigenetic discordance. Epigenetic differences are gaining increasing recognition. Although it is clear that in specific cases epigenetic alterations provide a causal factor in disease etiology, the overall significance of epigenetics in twin discordance remains unclear. It is also challenging to determine the causality and relative contributions of environmental, genetic, and stochastic factors to epigenetic variability. Epigenomic profiling studies have recently shed more light on the dynamics of temporal methylation change and methylome heritability, yet have not given a definite answer regarding their relevance to disease, because of limitations in establishing causality. Here, we explore the subject of epigenetics as another component in human phenotypic variability and its links to disease focusing particularly on evidence from MZ twin studies. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
5. An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene .
- Author
-
Ramagopalan, Sreeram V., McMahon, Roisin, Dyment, David A., Sadovnick, A. Dessa, Ebers, George C., and Wittkowski, Knut M.
- Subjects
MULTIPLE sclerosis ,NUCLEOTIDE sequence ,AMINO acids ,GENETIC disorders ,PEPTIDES - Abstract
Background: Multiple sclerosis (MS) is a complex trait in which genes in the MHC class II region exert the single strongest effect on genetic susceptibility. The principal MHC class II haplotype that increases MS risk in individuals of Northern European descent are those that bear HLA-DRB1*15. However, several other HLA-DRB1 alleles have been positively and negatively associated with MS and each of the main allelotypes is composed of many sub-allelotypes with slightly different sequence composition. Given the role of this locus in antigen presentation it has been suggested that variations in the peptide binding site of the allele may underlie allelic variation in disease risk. Methods: In an investigation of 7,333 individuals from 1,352 MS families, we assessed the nucleotide sequence of HLA-DRB1 for any effects on disease susceptibility extending a recently published method of statistical analysis for family-based association studies to the particular challenges of hyper-variable genetic regions. Results: We found that amino acid 60 of the HLA-DRB1 peptide sequence, which had previously been postulated based on structural features, is unlikely to play a major role. Instead, empirical evidence based on sequence information suggests that MS susceptibility arises primarily from amino acid 13. Conclusion: Identifying a single amino acid as a major risk factor provides major practical implications for risk and for the exploration of mechanisms, although the mechanism of amino acid 13 in the HLA-DRB1 sequence's involvement in MS as well as the identity of additional variants on MHC haplotypes that influence risk need to be uncovered. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
6. Methylation of class II transactivator gene promoter IV is not associated with susceptibility to Multiple Sclerosis.
- Author
-
Ramagopalan, Sreeram V., Dyment, David A., Morrison, Katie M., Herrera, Blanca M., DeLuca, Gabriele C., Lincoln, Matthew R., Orton, Sarah M., Handunnetthi, Lahiru, Chao, Michael J., Sadovnick, A. Dessa, and Ebers, George C.
- Subjects
MULTIPLE sclerosis ,GENETICS ,GENE expression ,GENES ,METHYLATION - Abstract
Background: Multiple sclerosis (MS) is a complex trait in which alleles at or near the class II loci HLA-DRB1 and HLA-DQB1 contribute significantly to genetic risk. The MHC class II transactivator (MHC2TA) is the master controller of expression of class II genes, and methylation of the promoter of this gene has been previously been shown to alter its function. In this study we sought to assess whether or not methylation of the MHC2TA promoter pIV could contribute to MS disease aetiology. Methods: In DNA from peripheral blood mononuclear cells from a sample of 50 monozygotic disease discordant MS twins the MHC2TA promoter IV was sequenced and analysed by methylation specific PCR. Results: No methylation or sequence variation of the MHC2TA promoter pIV was found. Conclusion: The results of this study cannot support the notion that methylation of the pIV promoter of MHC2TA contributes to MS disease risk, although tissue and timing specific epigenetic modifications cannot be ruled out. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
7. No effect of preterm birth on the risk of multiple sclerosis: a population based study.
- Author
-
Ramagopalan, Sreeram V., Valdar, William, Dyment, David A., DeLuca, Gabriele C., Orton, Sarah-Michelle, Yee, Irene M., Criscuoli, Maria, Ebers, George C., and Sadovnick, A. Dessa
- Subjects
PREMATURE labor ,MULTIPLE sclerosis ,GENETICS of disease susceptibility ,PREGNANCY ,GESTATIONAL age - Abstract
Background: Genetic and environmental factors have important roles in multiple sclerosis (MS) susceptibility. A clear parent of origin effect has been shown in several populations, perhaps resulting from factors operating during gestation. Preterm birth (birth at less than 37 weeks gestational age) has been shown to result in long-term health problems, including impaired neurological development. Here, in a population-based cohort, we investigate whether preterm birth increases the risk to subsequently develop MS. Methods: We identified 6585 MS index cases and 2509 spousal controls with preterm birth information from the Canadian Collaborative Project on Genetic Susceptibility to MS. Rates of individuals born preterm were compared for index cases and controls. Results: There were no significant differences between cases and controls with respect to preterm births. 370 (5.6%) MS index cases and 130 (5.2%) spousal controls were born preterm, p = 0.41. Conclusion: Preterm birth does not appear to contribute to MS aetiology. Other factors involved in foetal and early development need to be explored to elucidate the mechanism of the increased risk conferred by the apparent maternal effect. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
8. Reducing the probability of false positive research findings by pre-publication validation -- Experience with a large multiple sclerosis database.
- Author
-
Daumer, Martin, Held, Ulrike, Ickstadt, Katja, Heinz, Moritz, Schach, Siegfried, and Ebers, George
- Subjects
PROBABILITY theory ,RESEARCH bias ,MULTIPLE sclerosis research ,INFORMATION storage & retrieval systems ,STATISTICAL reliability ,CLINICAL trials ,MEDICAL research methodology - Abstract
Background: Published false positive research findings are a major problem in the process of scientific discovery. There is a high rate of lack of replication of results in clinical research in general, multiple sclerosis research being no exception. Our aim was to develop and implement a policy that reduces the probability of publishing false positive research findings. We have assessed the utility to work with a pre-publication validation policy after several years of research in the context of a large multiple sclerosis database. Methods: The large database of the Sylvia Lawry Centre for Multiple Sclerosis Research was split in two parts: one for hypothesis generation and a validation part for confirmation of selected results. We present case studies from 5 finalized projects that have used the validation policy and results from a simulation study. Results: In one project, the "relapse and disability" project as described in section II (example 3), findings could not be confirmed in the validation part of the database. The simulation study showed that the percentage of false positive findings can exceed 20% depending on variable selection. Conclusion: We conclude that the validation policy has prevented the publication of at least one research finding that could not be validated in an independent data set (and probably would have been a "true" false-positive finding) over the past three years, and has led to improved data analysis, statistical programming, and selection of hypotheses. The advantages outweigh the lost statistical power inherent in the process. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
9. Congenital Abnormalities and Multiple Sclerosis.
- Author
-
Ramagopalan, Sreeram V., Guimond, Colleen, Criscuoli, Maria, Dyment, David A., Orton, Sarah-Michelle, Yee, Irene M., Ebers, George C., and Sadovnick, Dessa
- Subjects
HUMAN abnormalities ,MULTIPLE sclerosis ,VIRUS diseases ,MYELIN sheath diseases ,NEUROLOGY - Abstract
Background: There is a strong maternal parent-of-origin effect in determining susceptibility to multiple sclerosis (MS). One hypothesis is that an abnormal intrauterine milieu leading to impaired fetal development could plausibly also result in increased susceptibility to MS. A possible marker for this intrauterine insult is the presence of a nonfatal congenital anomaly. Methods: We investigated whether or not congenital anomalies are associated with MS in a population-based cohort. We identified 7063 MS index cases and 2655 spousal controls with congenital anomaly information from the Canadian Collaborative Project on Genetic Susceptibility to MS (CCPGSMS). Results: The frequency of congential anomalies were compared between index cases and controls. No significant differences were found. Conclusions: Congenital anomalies thus do not appear to be associated with MS. However, we did not have complete data on types and severity of congenital anomalies or on maternal birth history and thus this study should be regarded as preliminary. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
10. No effect of preterm birth on the risk of multiple sclerosis: a population based study
- Author
-
Ramagopalan, Sreeram V, Valdar, William, Dyment, David A, DeLuca, Gabriele C, Orton, Sarah-Michelle, Yee, Irene M, Criscuoli, Maria, Ebers, George C, and Sadovnick, A D
- Subjects
3. Good health - Abstract
Background: Genetic and environmental factors have important roles in multiple sclerosis (MS) susceptibility. A clear parent of origin effect has been shown in several populations, perhaps resulting from factors operating during gestation. Preterm birth (birth at less than 37 weeks gestational age) has been shown to result in long-term health problems, including impaired neurological development. Here, in a population-based cohort, we investigate whether preterm birth increases the risk to subsequently develop MS. Methods: We identified 6585 MS index cases and 2509 spousal controls with preterm birth information from the Canadian Collaborative Project on Genetic Susceptibility to MS. Rates of individuals born preterm were compared for index cases and controls. Results: There were no significant differences between cases and controls with respect to preterm births. 370 (5.6%) MS index cases and 130 (5.2%) spousal controls were born preterm, p = 0.41. Conclusion: Preterm birth does not appear to contribute to MS aetiology. Other factors involved in foetal and early development need to be explored to elucidate the mechanism of the increased risk conferred by the apparent maternal effect.
11. Month of birth, vitamin D and risk of immune-mediated disease: a case control study.
- Author
-
Disanto G, Chaplin G, Morahan JM, Giovannoni G, Hyppönen E, Ebers GC, and Ramagopalan SV
- Subjects
- Adult, Autoimmune Diseases blood, Case-Control Studies, Colitis, Ulcerative blood, Colitis, Ulcerative epidemiology, Crohn Disease blood, Crohn Disease epidemiology, Female, Humans, Male, Middle Aged, Multiple Sclerosis blood, Multiple Sclerosis epidemiology, Odds Ratio, Risk Factors, Sunlight, Ultraviolet Rays, Autoimmune Diseases epidemiology, Seasons, Vitamin D blood
- Abstract
Background: A season of birth effect in immune-mediated diseases (ID) such as multiple sclerosis and type 1 diabetes has been consistently reported. We aimed to investigate whether season of birth influences the risk of rheumatoid arthritis, Crohn's disease, ulcerative colitis and systemic lupus erythematosus in addition to multiple sclerosis, and to explore the correlation between the risk of ID and predicted ultraviolet B (UVB) light exposure and vitamin D status during gestation., Methods: The monthly distribution of births of patients with ID from the UK (n = 115,172) was compared to that of the general population using the Cosinor test. Predicted UVB radiation and vitamin D status in different time windows during pregnancy were calculated for each month of birth and correlated with risk of ID using the Spearman's correlation coefficient., Results: The distributions of ID births significantly differed from that of the general population (P = 5e-12) with a peak in April (odds ratio = 1.045, 95% confidence interval = 1.024, 1.067, P < 0.0001) and a trough in October (odds ratio = 0.945, 95% confidence interval = 0.925, 0.966, P < 0.0001). Stratification by disease subtype showed seasonality in all ID but Crohn's disease. The risk of ID was inversely correlated with predicted second trimester UVB exposure (Spearman's rho = -0.49, P = 0.00005) and third trimester vitamin D status (Spearman's rho = -0.44, P = 0.0003)., Conclusions: The risk of different ID in the UK is significantly influenced by the season of birth, suggesting the presence of a shared seasonal risk factor or factors predisposing to ID. Gestational UVB and vitamin D exposure may be implicated in the aetiology of ID.
- Published
- 2012
- Full Text
- View/download PDF
12. Multiple sclerosis: major histocompatibility complexity and antigen presentation.
- Author
-
Ramagopalan SV and Ebers GC
- Abstract
Multiple sclerosis (MS), like many putative autoimmune diseases, has been known to be associated with the human leukocyte antigen (HLA) class II region for more than 3 decades. However, exactly how HLA class II alleles increase the risk of MS is not yet conclusively known. Recent work in large human cohorts has highlighted the fact that nearly all common HLA-DRB1 allelotypes are either positively or negatively associated with the disease, detracting from allele-specific antigen presentation as the sole mechanism of MHC associated disease susceptibility. Here, we put into context recent data on the HLA class II region in MS, including allelic heterogeneity, gene-environment interactions and epigenetics. It is clear that a complete understanding of the epistatic interactions and epigenetic features of this region will be crucial to comprehending disease pathogenesis.
- Published
- 2009
- Full Text
- View/download PDF
13. The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.
- Author
-
Pickin M, Cooper CL, Chater T, O'Hagan A, Abrams KR, Cooper NJ, Boggild M, Palace J, Ebers G, Chilcott JB, Tappenden P, and Nicholl J
- Subjects
- Adult, Cost-Benefit Analysis, Female, Follow-Up Studies, Glatiramer Acetate, Health Care Costs, Humans, Immunologic Factors therapeutic use, Immunosuppressive Agents therapeutic use, Male, Middle Aged, Organizational Case Studies, Prospective Studies, United Kingdom, Interferon-beta therapeutic use, Multiple Sclerosis drug therapy, Multiple Sclerosis economics, Outcome Assessment, Health Care economics, Peptides therapeutic use, Risk Sharing, Financial
- Abstract
Background: Risk sharing schemes represent an innovative and important approach to the problems of rationing and achieving cost-effectiveness in high cost or controversial health interventions. This study aimed to assess the feasibility of risk sharing schemes, looking at long term clinical outcomes, to determine the price at which high cost treatments would be acceptable to the NHS., Methods: This case study of the first NHS risk sharing scheme, a long term prospective cohort study of beta interferon and glatiramer acetate in multiple sclerosis (MS) patients in 71 specialist MS centres in UK NHS hospitals, recruited adults with relapsing forms of MS, meeting Association of British Neurologists (ABN) criteria for disease modifying therapy. Outcome measures were: success of recruitment and follow up over the first three years, analysis of baseline and initial follow up data and the prospect of estimating the long term cost-effectiveness of these treatments., Results: Centres consented 5560 patients. Of the 4240 patients who had been in the study for a least one year, annual review data were available for 3730 (88.0%). Of the patients who had been in the study for at least two years and three years, subsequent annual review data were available for 2055 (78.5%) and 265 (71.8%) patients respectively. Baseline characteristics and a small but statistically significant progression of disease were similar to those reported in previous pivotal studies., Conclusion: Successful recruitment, follow up and early data analysis suggest that risk sharing schemes should be able to deliver their objectives. However, important issues of analysis, and political and commercial conflicts of interest still need to be addressed.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.